Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
PDGFRB overexpression
i
Other names:
PDGFRB, Platelet Derived Growth Factor Receptor Beta, Platelet-Derived Growth Factor Receptor, Beta Polypeptide, Beta-Type Platelet-Derived Growth Factor Receptor, Platelet-Derived Growth Factor Receptor Beta, Platelet-Derived Growth Factor Receptor 1, CD140 Antigen-Like Family Member B, PDGF-R-Beta, PDGFR-Beta, PDGFR-1, PDGFR1,Beta Platelet-Derived Growth Factor Receptor, Activated Tyrosine Kinase PDGFRB, CD140b Antigen, NDEL1-PDGFRB , CD140B, IBGC4, JTK12, PENTT, IMF1 , KOGS
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
5159
Related biomarkers:
Expression
Mutation
Fusion
Others
‹
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
PDGFRB overexpression
Colorectal Cancer
PDGFRB overexpression
Colorectal Cancer
ARO-002
Sensitive: C3 – Early Trials
ARO-002
Sensitive
:
C3
ARO-002
Sensitive: C3 – Early Trials
ARO-002
Sensitive
:
C3
PDGFRB overexpression
Osteosarcoma
PDGFRB overexpression
Osteosarcoma
anlotinib
Sensitive: C3 – Early Trials
anlotinib
Sensitive
:
C3
anlotinib
Sensitive: C3 – Early Trials
anlotinib
Sensitive
:
C3
PDGFRB overexpression
Sarcoma
PDGFRB overexpression
Sarcoma
pazopanib
Sensitive: C4 – Case Studies
pazopanib
Sensitive
:
C4
pazopanib
Sensitive: C4 – Case Studies
pazopanib
Sensitive
:
C4
PDGFRB overexpression
Thyroid Gland Papillary Carcinoma
PDGFRB overexpression
Thyroid Gland Papillary Carcinoma
larotrectinib
Sensitive: C4 – Case Studies
larotrectinib
Sensitive
:
C4
larotrectinib
Sensitive: C4 – Case Studies
larotrectinib
Sensitive
:
C4
PDGFRB overexpression
Hepatocellular Cancer
PDGFRB overexpression
Hepatocellular Cancer
Tyrosine kinase inhibitor
Sensitive: D – Preclinical
Tyrosine kinase inhibitor
Sensitive
:
D
Tyrosine kinase inhibitor
Sensitive: D – Preclinical
Tyrosine kinase inhibitor
Sensitive
:
D
PDGFRB overexpression
Melanoma
PDGFRB overexpression
Melanoma
vemurafenib
Resistant: D – Preclinical
vemurafenib
Resistant
:
D
vemurafenib
Resistant: D – Preclinical
vemurafenib
Resistant
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login